Difference between revisions of "Amitriptyline-maprotiline"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{Drugswitch | from = amitriptyline | to = maprotiline | stop = * Gradually reduce dosage of amitriptyline to a maximum of 50-100 mg/day. * When a dosage of 50-100 mg/day is...')
 
Line 7: Line 7:
 
| start =  
 
| start =  
 
* No wash-out period is needed.  
 
* No wash-out period is needed.  
* Start administration of maprotiline the next day in a normal dosage of 25-75 mg/day.}}
+
* Start administration of maprotiline the next day in a normal dosage of 25-75 mg/day.
 +
|info =
 +
{{review}}
 +
}}

Revision as of 17:46, 28 October 2015

Amitriptyline
Type Antidepressant
Group TCA
links
ATC-code N06AA09
Medscape Amitriptyline
PubChem 2160
PubMed Amitriptyline
Kompas (Dutch) Amitriptyline
Wikipedia Amitriptyline
Maprotiline
Type Antidepressant
Group NRI
links
Medscape Maprotiline
PubChem 4011
PubMed Maprotiline
Kompas (Dutch) Maprotiline
Wikipedia Maprotiline

Switch medication from amitriptyline to maprotiline.

Nietinrijdenbord.png Stop amitriptyline
  • Gradually reduce dosage of amitriptyline to a maximum of 50-100 mg/day.
  • When a dosage of 50-100 mg/day is reached, stop administration.
Eenrichtingbord.png Start maprotiline
  • No wash-out period is needed.
  • Start administration of maprotiline the next day in a normal dosage of 25-75 mg/day.
Infobord.png More information
  • This switch is currently being reviewed.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.